Biological E gets CDSCO panel’s nod for human trial of Baylor's covid vaccine2 min read . Updated: 28 Oct 2020, 05:28 PM IST
- A recommendation from the subject expert committee in the Central Drugs Standards Control Organisation (CDSCO) is usually followed by approval from the DCGI, and the application is currently being processed
NEW DELHI : A CDSCO panel has recommended to the Drug Controller General of India, V.G. Somani to allow Biological E Ltd to conduct phase 1 and 2 clinical trial of the covid-19 vaccine in India, a source in the know said. The vaccine has been developed by US-based Baylor College of Medicine.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more